BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Business

  Gilead Sciences Announces Third Quarter 2022 Financial Results

  Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the third quarter of 2022.

  October 27, 2022

   · 

  35 min read
• BioMidwest

  Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States

  Sonoma Pharmaceuticals, Inc. announced that it has launched Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel and Rejuvacyn® Advanced Skin Repair Cooling Mist direct to consumers for over-the-counter use in the United States.

  October 27, 2022

   · 

  5 min read
• Genetown

  Moderna to Host First Environmental, Social and Governance (ESG) Day on November 10, 2022

  Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that it will host its first virtual ESG Day for analysts and investors at 9:00 a.m. ET on Thursday, November 10.

  October 27, 2022

   · 

  1 min read
• Business

  Dexcom Reports Third Quarter 2022 Financial Results

  DexCom, Inc. reported its financial results as of and for the quarter ended September 30, 2022.

  October 27, 2022

   · 

  18 min read
• Business

  enVVeno Medical Reports Third Quarter 2022 Financial Results and Provides Corporate Update

  enVVeno Medical Corporation, a company setting new standards of care for the treatment of venous disease, provided a corporate update and reported financial results for the third quarter ended September 30, 2022.

  October 27, 2022

   · 

  6 min read
• Autologous Cell Therapy Market Size to Surpass USD 34.94 BN by 2030

  According to Latest Report Study, the global autologous cell therapy market is predicted to surpass around USD 34.94 billion by 2030 with a CAGR of 18.13% from 2022 to 2030.

  October 27, 2022

   · 

  6 min read
• AI In Cancer Diagnostics Market Size USD 1.2 BN by 2030 With a CAGR of 28.9%

  Latest Study on “AI In Cancer Diagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.

  October 27, 2022

   · 

  5 min read
• Business

  Ventyx Biosciences to Report Third Quarter 2022 Financial Results on November 3, 2022

  Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”) today announced that it will report financial results for the third quarter ended September 30, 2022 after market close on November 3, 2022.

  October 27, 2022

   · 

  3 min read
• Business

  Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter 2022 Financial Results on November 3, 2022

  Corvus Pharmaceuticals, Inc. announced that the Company will host a conference call and webcast on November 3, 2022 at 4:30 pm ET to provide a business update and report third quarter 2022 financial results.

  October 27, 2022

   · 

  1 min read
• Business

  ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023

  ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2022.

  October 27, 2022

   · 

  15 min read